Shandong Wohua Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shandong Wohua Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Chengdu Taihe Health Technology Group Inc Ltd
sales of 575.04 million Chinese Renmimbi [US$84.98 million]
of which 78%
was Medicine Manufacturing),
Hunan Fangsheng Pharmaceutical Co Ltd
(534.20 million Chinese Renmimbi [US$78.94 million]
of which 83%
was pharmaceutical manufacturing), and
Ningbo Menovo Pharmaceutical Co Ltd
(578.08 million Chinese Renmimbi [US$85.43 million]
During the year ended December of 2016, sales at
Shandong Wohua Pharmaceutical Co., Ltd. were 562.80 million Chinese Renmimbi (US$83.17 million).
increase of 20.0%
versus 2015, when the company's sales were 468.92 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shandong Wohua Pharmaceutical Co., Ltd.
(and since 2011, sales have increased a total of 278%).
Sales of Medical Industry saw an increase
20.1% in 2016, from
466.98 million Chinese Renmimbi to 560.84 million Chinese Renmimbi.